Cytek Biosciences Stock Price History
CTKB Stock | USD 3.40 0.01 0.29% |
Below is the normalized historical share price chart for Cytek Biosciences extending back to July 23, 2021. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cytek Biosciences stands at 3.40, as last reported on the 28th of September, with the highest price reaching 3.47 and the lowest price hitting 3.37 during the day.
If you're considering investing in Cytek Stock, it is important to understand the factors that can impact its price. At this point, Cytek Biosciences is relatively risky. Cytek Biosciences secures Sharpe Ratio (or Efficiency) of 0.0188, which signifies that the company had a 0.0188 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Cytek Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Cytek Biosciences' Mean Deviation of 2.93, downside deviation of 3.88, and Risk Adjusted Performance of 0.0254 to double-check if the risk estimate we provide is consistent with the expected return of 0.0721%. At present, Cytek Biosciences' Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation To Revenue is expected to grow to 0.14, whereas Total Stockholder Equity is forecasted to decline to about 286.5 M. . At present, Cytek Biosciences' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 3.03, whereas Price To Sales Ratio is forecasted to decline to 4.02. Cytek Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 23rd of July 2021 | 200 Day MA 4.272 | 50 Day MA 3.8398 | Beta 1.359 |
Sharpe Ratio = 0.0188
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | CTKB | Huge Risk |
Negative Returns |
Estimated Market Risk
3.83 actual daily | 34 66% of assets are more volatile |
Expected Return
0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Cytek Biosciences is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cytek Biosciences by adding it to a well-diversified portfolio.
Price Book 1.1457 | Enterprise Value Ebitda (133.96) | Price Sales 2.2065 | Shares Float 108.7 M | Wall Street Target Price 5.125 |
Cytek Biosciences Stock Price History Chart
There are several ways to analyze Cytek Stock price data. The simplest method is using a basic Cytek candlestick price chart, which shows Cytek Biosciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | August 13, 2025 | 4.17 |
Lowest Price | July 21, 2025 | 3.1 |
Cytek Biosciences September 28, 2025 Stock Price Synopsis
Various analyses of Cytek Biosciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cytek Stock. It can be used to describe the percentage change in the price of Cytek Biosciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cytek Stock.Cytek Biosciences Price Rate Of Daily Change | 1.00 | |
Cytek Biosciences Price Action Indicator | (0.02) | |
Cytek Biosciences Price Daily Balance Of Power | 0.10 |
Cytek Biosciences September 28, 2025 Stock Price Analysis
Cytek Stock Price History Data
The price series of Cytek Biosciences for the period between Mon, Jun 30, 2025 and Sun, Sep 28, 2025 has a statistical range of 1.07 with a coefficient of variation of 8.29. The prices are distributed with arithmetic mean of 3.75. The median price for the last 90 days is 3.79.Open | High | Low | Close | Volume | ||
09/28/2025 | 3.39 | 3.47 | 3.37 | 3.40 | ||
09/26/2025 | 3.39 | 3.47 | 3.37 | 3.40 | 719,646 | |
09/25/2025 | 3.38 | 3.47 | 3.28 | 3.39 | 893,909 | |
09/24/2025 | 3.70 | 3.72 | 3.40 | 3.41 | 652,085 | |
09/23/2025 | 3.88 | 3.95 | 3.70 | 3.71 | 584,395 | |
09/22/2025 | 3.79 | 3.95 | 3.71 | 3.86 | 964,664 | |
09/19/2025 | 4.09 | 4.09 | 3.78 | 3.78 | 1,986,594 | |
09/18/2025 | 3.98 | 4.12 | 3.97 | 4.09 | 718,969 | |
09/17/2025 | 3.91 | 4.17 | 3.88 | 3.92 | 926,573 | |
09/16/2025 | 3.93 | 3.97 | 3.86 | 3.90 | 735,747 | |
09/15/2025 | 3.94 | 4.09 | 3.80 | 3.96 | 975,576 | |
09/12/2025 | 4.12 | 4.12 | 3.93 | 3.94 | 974,107 | |
09/11/2025 | 3.76 | 4.14 | 3.73 | 4.13 | 1,167,422 | |
09/10/2025 | 3.93 | 4.00 | 3.72 | 3.74 | 1,022,928 | |
09/09/2025 | 4.07 | 4.11 | 3.91 | 3.93 | 776,748 | |
09/08/2025 | 4.03 | 4.21 | 4.03 | 4.10 | 1,069,517 | |
09/05/2025 | 3.99 | 4.10 | 3.91 | 4.02 | 713,443 | |
09/04/2025 | 3.94 | 4.01 | 3.85 | 3.98 | 787,119 | |
09/03/2025 | 3.96 | 4.08 | 3.91 | 3.94 | 1,023,893 | |
09/02/2025 | 4.10 | 4.12 | 3.95 | 4.02 | 832,106 | |
08/29/2025 | 4.19 | 4.20 | 4.09 | 4.14 | 735,856 | |
08/28/2025 | 4.13 | 4.20 | 4.05 | 4.17 | 1,279,235 | |
08/27/2025 | 4.16 | 4.23 | 4.05 | 4.09 | 803,945 | |
08/26/2025 | 4.22 | 4.22 | 4.02 | 4.16 | 2,611,110 | |
08/25/2025 | 4.15 | 4.20 | 4.10 | 4.11 | 804,706 | |
08/22/2025 | 4.04 | 4.28 | 4.04 | 4.15 | 782,501 | |
08/21/2025 | 4.00 | 4.10 | 3.91 | 4.01 | 567,062 | |
08/20/2025 | 4.03 | 4.08 | 3.98 | 4.00 | 544,791 | |
08/19/2025 | 4.00 | 4.14 | 4.00 | 4.04 | 691,690 | |
08/18/2025 | 3.95 | 4.17 | 3.94 | 4.06 | 493,217 | |
08/15/2025 | 4.12 | 4.14 | 3.99 | 4.01 | 729,354 | |
08/14/2025 | 4.07 | 4.13 | 3.99 | 4.08 | 1,027,117 | |
08/13/2025 | 4.09 | 4.19 | 4.04 | 4.17 | 1,346,200 | |
08/12/2025 | 3.85 | 4.09 | 3.83 | 4.03 | 1,306,205 | |
08/11/2025 | 4.00 | 4.02 | 3.68 | 3.79 | 1,665,993 | |
08/08/2025 | 4.10 | 4.10 | 3.90 | 4.03 | 1,543,294 | |
08/07/2025 | 3.89 | 4.19 | 3.80 | 4.11 | 1,485,004 | |
08/06/2025 | 3.85 | 3.98 | 3.81 | 3.89 | 1,606,457 | |
08/05/2025 | 3.83 | 3.94 | 3.80 | 3.88 | 1,107,853 | |
08/04/2025 | 3.64 | 3.86 | 3.62 | 3.84 | 1,279,542 | |
08/01/2025 | 3.46 | 3.67 | 3.44 | 3.64 | 1,548,562 | |
07/31/2025 | 3.49 | 3.61 | 3.46 | 3.60 | 1,544,731 | |
07/30/2025 | 3.64 | 3.69 | 3.46 | 3.55 | 1,382,855 | |
07/29/2025 | 3.77 | 3.78 | 3.60 | 3.60 | 797,419 | |
07/28/2025 | 3.69 | 3.78 | 3.66 | 3.75 | 1,138,536 | |
07/25/2025 | 3.40 | 3.71 | 3.38 | 3.69 | 1,647,988 | |
07/24/2025 | 3.20 | 3.39 | 3.20 | 3.33 | 705,753 | |
07/23/2025 | 3.31 | 3.44 | 3.26 | 3.37 | 780,585 | |
07/22/2025 | 3.11 | 3.26 | 3.09 | 3.25 | 612,773 | |
07/21/2025 | 3.16 | 3.21 | 3.09 | 3.10 | 452,402 | |
07/18/2025 | 3.34 | 3.34 | 3.10 | 3.13 | 714,730 | |
07/17/2025 | 3.26 | 3.38 | 3.25 | 3.30 | 775,307 | |
07/16/2025 | 3.29 | 3.34 | 3.22 | 3.24 | 788,508 | |
07/15/2025 | 3.36 | 3.40 | 3.21 | 3.25 | 1,147,279 | |
07/14/2025 | 3.41 | 3.44 | 3.26 | 3.35 | 1,016,967 | |
07/11/2025 | 3.53 | 3.55 | 3.43 | 3.45 | 441,456 | |
07/10/2025 | 3.54 | 3.63 | 3.48 | 3.56 | 642,705 | |
07/09/2025 | 3.47 | 3.62 | 3.46 | 3.58 | 862,398 | |
07/08/2025 | 3.40 | 3.48 | 3.26 | 3.43 | 2,459,205 | |
07/07/2025 | 3.71 | 3.72 | 3.39 | 3.40 | 743,911 | |
07/03/2025 | 3.62 | 3.82 | 3.59 | 3.76 | 776,901 |
About Cytek Biosciences Stock history
Cytek Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cytek is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cytek Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cytek Biosciences stock prices may prove useful in developing a viable investing in Cytek Biosciences
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 130.6 M | 107.2 M | |
Net Income Applicable To Common Shares | 3 M | 3.1 M |
Cytek Biosciences Quarterly Net Working Capital |
|
Cytek Biosciences Stock Technical Analysis
Cytek Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
All Next | Launch Module |
Cytek Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cytek Biosciences' price direction in advance. Along with the technical and fundamental analysis of Cytek Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cytek to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0254 | |||
Jensen Alpha | (0.25) | |||
Total Risk Alpha | (0.54) | |||
Sortino Ratio | (0) | |||
Treynor Ratio | 0.029 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Cytek Stock analysis
When running Cytek Biosciences' price analysis, check to measure Cytek Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytek Biosciences is operating at the current time. Most of Cytek Biosciences' value examination focuses on studying past and present price action to predict the probability of Cytek Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytek Biosciences' price. Additionally, you may evaluate how the addition of Cytek Biosciences to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |